Farahnak Assadi
1* 
1 Department of Pediatrics, Division of Nephrology, Rush University Medical Center, 445 E. North Water Street, Suite 1804, Chicago, Illinois, USA
*Corresponding Author: Department of Pediatrics, Division of Nephrology, Rush University Medical Center, 445 E. North Water Street, Suite 1804, Chicago, Illinois, USA, Email:
Implication for health policy/practice/research/medical education:
There is no information available on the efficacy of acetazolamide on the management of
severe hypokalemic alkalosis refractory to the standard therapy. A benefit from acetazolamide
appears to be apparent in the management of hypokalemic alkalosis in patients with Barter
syndrome.
Please cite this paper as: Assadi F. Acetazolamide therapy for hypokalemic alkalosis in
Bartter syndrome. J Renal Inj Prev. 2019; 8(3): 169-171. DOI: 10.15171/jrip.2019.31.